Medicare Enrolled
Dr. Ryan Kendle, M.D.
Hematology & Oncology · Santa Barbara, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kendle from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kendle?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kendle
Dr. Ryan Kendle is a hematology & oncology specialist in Santa Barbara, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Kendle performed 9,546 Medicare services across 609 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kendle received a total of $4,989 from 47 pharmaceutical and/or device companies across 160 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kendle is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 29% volume in CA
$4,989 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,546
Medicare services
Top 29% in CA for hematology & oncology
609
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~636 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
4,801 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 2,160 | $18 | $50 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
772 | $0 | $0 |
| Anti-nausea injection (Aloxi/palonosetron) | 380 | $1 | $9 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
273 | $106 | $353 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
178 | $116 | $486 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
120 | $63 | $250 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
118 | $14 | $65 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
116 | $12 | $69 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
89 | $144 | $491 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
71 | $58 | $199 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
67 | $11 | $45 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
62 | $29 | $158 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
61 | $2 | $7 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
59 | $25 | $106 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
56 | $30 | $115 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
47 | $57 | $240 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
45 | $25 | $114 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
43 | $24 | $80 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
15 | $141 | $453 |
| Online digital E/M service, established patient, 11-20 min An online digital evaluation and management service for an established patient. The service involves a total time of 11 to 20 minutes over a period of up to 7 days. |
13 | $22 | $81 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.0% high complexity
88.5% medium
6.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,989
Total received (2018-2024)
Avg $713/year across 7 years
Top 43% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
160
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,883 (97.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$89 (1.8%)
Other
Charitable contributions, space rental, and other categories
$17 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,117
2023
$629
2022
$843
2021
$69
2020
$67
2019
$1,181
2018
$1,084
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$162
AstraZeneca Pharmaceuticals LP
$152
Novartis Pharmaceuticals Corporation
$147
Monteris Medical Corporation
$117
Astellas Pharma US Inc
$95
E.R. Squibb & Sons, L.L.C.
$89
Adaptive Biotechnologies Corporation
$61
Janssen Biotech, Inc.
$52
ABBVIE INC.
$35
Apellis Pharmaceuticals, Inc.
$30
Incyte Corporation
$29
Celgene Corporation
$26
Takeda Pharmaceuticals U.S.A., Inc.
$24
Lilly USA, LLC
$24
PFIZER INC.
$23
Melinta Therapeutics, LLC
$18
Agios Pharmaceuticals, Inc.
$18
SOBI, INC
$14
Top 3 companies account for 41.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$560
Novartis Pharmaceuticals Corporation
$452
E.R. Squibb & Sons, L.L.C.
$448
Janssen Biotech, Inc.
$373
ABBVIE INC.
$280
Alexion Pharmaceuticals, Inc.
$262
Lilly USA, LLC
$194
EMD Serono, Inc.
$181
AbbVie, Inc.
$173
Takeda Pharmaceuticals U.S.A., Inc.
$149
ADC Therapeutics America, Inc.
$130
BeiGene USA, Inc.
$125
Monteris Medical Corporation
$117
GENZYME CORPORATION
$117
Jazz Pharmaceuticals Inc.
$106
GlaxoSmithKline, LLC.
$101
Celgene Corporation
$98
Astellas Pharma US Inc
$95
EISAI INC.
$88
Incyte Corporation
$83
TESARO, Inc.
$71
Janssen Scientific Affairs, LLC
$66
Regeneron Healthcare Solutions, Inc.
$64
Adaptive Biotechnologies Corporation
$61
Exelixis Inc.
$55
Genentech USA, Inc.
$52
PFIZER INC.
$49
Amgen Inc.
$42
Puma Biotechnology, Inc.
$38
PORTOLA PHARMACEUTICALS, INC.
$32
Apellis Pharmaceuticals, Inc.
$30
Seagen Inc.
$26
Rigel Pharmaceuticals, Inc.
$25
EUSA Pharma (US) LLC
$24
Daiichi Sankyo Inc.
$23
Seattle Genetics, Inc.
$20
Flowonix Medical Incorporated
$19
Melinta Therapeutics, LLC
$18
Agios Pharmaceuticals, Inc.
$18
Merck Sharp & Dohme Corporation
$17
Welch Allyn
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Pharmacyclics LLC, An AbbVie Company
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
McKesson Specialty Care Distribution, LLC
$15
SOBI, INC
$14
Lexicon Pharmaceuticals, Inc.
$14
Top 3 companies account for 29.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · ANDEXXA · Avastin · BAVENCIO · BRUKINSA · CALQUENCE · CARVYKTI · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · ELITEK · ELREXFIO · ENHERTU · ERLEADA · Empaveli · FASLODEX · FRUZAQLA · GAZYVA · GILOTRIF · ICLUSIG · IMBRUVICA · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · LIBTAYO · LYNPARZA · Lenvima · Lupron · Lupron Depot · MEKINIST · NINLARO · Nerlynx · Neulasta · Neuroblate · None · Nplate · ONUREG · OPDIVO · PROMACTA · PYRUKYND · Prometra II · REBLOZYL · Rezzayo · SCEMBLIX · SOLIRIS · Sylvant · TAGRISSO · TECVAYLI · TEPMETKO · Tavalisse · ULTOMIRIS · VENCLEXTA · VERZENIO · VYXEOS · Venclexta · Vyloy · Xermelo · Xofigo · ZEJULA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
18
Per 100K population
4.1
County median income
$95,977
Nearest hospital
SANTA BARBARA COTTAGE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kendle is a mixed practice specialist, with above-average Medicare volume (top 29% in CA), with low-engagement industry engagement, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kendle experienced with anti-nausea injection (fosaprepitant)?
Based on Medicare claims data, Dr. Kendle performed 4,801 anti-nausea injection (fosaprepitant) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kendle receive payments from pharmaceutical companies?
Yes. Dr. Kendle received a total of $4,989 from 47 companies across 160 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kendle's costs compare to other hematology & oncology specialists in Santa Barbara?
Dr. Kendle's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kendle) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Santa Barbara
Browse hematology & oncology specialists in Santa Barbara ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology